Overall, TAMs play a dual role as “tumor promoters” and “immune suppressors” because they can promote tumor initiation and act as central drivers of the immunosuppressive TME through their expression of cell surface receptors, secreted cytokines, chemokines, and enzymes that regulate the recruitment and function of multiple immune cell subtypes. Here, CD177 is linked to neoplasm.